A non-selective COX inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Eltenac

Item No. 27673

Technical Information
Formal Name
4-[(2,6-dichlorophenyl)amino]-3-thiopheneacetic acid
CAS Number
72895-88-6
Molecular Formula
C12H9Cl2NO2S
Formula Weight
Purity
≥98%
Formulation
A solid
DMF: solubleDMSO: solubleMethanol: soluble
SMILES
ClC1=C(NC2=CSC=C2CC(O)=O)C(Cl)=CC=C1
InChi Code
InChI=1S/C12H9Cl2NO2S/c13-8-2-1-3-9(14)12(8)15-10-6-18-5-7(10)4-11(16)17/h1-3,5-6,15H,4H2,(H,16,17)
InChi Key
AELILMBZWCGOSB-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    Eltenac is a non-selective COX inhibitor (IC50 = 0.03 µM for both COX-1 and COX-2 in isolated human whole blood) and a non-steroidal anti-inflammatory drug (NSAID).1 In vivo, eltenac (1 mg/kg) reduces lameness in horses with tendinitis, pododermatitis, navicular disease, non-infectious arthritis, degenerative joint disease, phalanx fracture, and osteochondrosis.2 It also reduces castration-induced edema in horses. Formulations containing eltenac have been used in the treatment of postoperative swelling in horses.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Klein, T., Dullweber, F., Brehm, C., et alCharacterization of eltenac and novel COX-2 selective thiopheneacetic acid analogues in vitro and in vivo. Biochem. Pharmacol. 76(6), 717-725 (2008).

    2. Prügner, W., Huber, R., and Lühmann, R. Eltenac, a new anti-inflammatory and analgesic drug for horses: clinical aspects. J. Vet. Pharmacol. Ther. 14(2), 193-199 (1991).